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Edited by Beat ImhofAbstract Protein kinase D (PKD) has been implicated in the
regulation of cell shape, adhesion, and migration. At the leading
edge of migrating cells active PKD co-localizes with F-actin,
Arp3 and cortactin. Platelet derived growth factor (PDGF) acti-
vates PKD and recruits the kinase to the leading edge, suggest-
ing a role for PKD in actin remodelling. In support of this, PKD
directly interacts with F-actin and phosphorylates cortactin
in vitro. Interference with PKD function by overexpression of
a dominant negative PKD or by PKD-speciﬁc siRNA enhanced
cell migration, whereas cells overexpressing PKD wild type dis-
played reduced migratory potential. Taken together, these data
reveal a negative regulatory function of PKD in cell migration.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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The Protein kinase D (PKD) family of serine/threonine ki-
nases consists of three structurally related isoforms: PKD1,
PKD2 and PKD3. They are broadly expressed in most tissues
and have been implicated in various fundamental cellular func-
tions (reviewed in [1,2]). PKDs display dynamic changes in
intracellular localization, they are recruited to the trans-Golgi
network (TGN) and the plasma membrane in a diacylglycerol
(DAG) dependent manner, a prerequisite for transphosphoryl-
ation and activation by nPKCs [3,4], but may also shuttle be-
tween cytosol and nucleus [5,6].
Several studies indicated a role for PKD in regulation of cell
shape, motility, and adhesion. PKD was proposed to form a
complex with the actin-binding protein cortactin and the focal
adhesion protein paxillin in breast cancer cell invadopodia [7].
However, the speciﬁc role of PKD in this complex remained
undeﬁned. Another link of PKD to cell migration is given with
its substrate Kidins220 which is localized at neurite tips and
growth cones of PC12 cells [8]. In motile immature dendritic
cells, Kidins220 was localized to a raft compartment of mem-
brane protrusions at the leading edge of migrating cells [9].
Co-localization of PKD in these structures supported a roleAbbreviations: DAG, diacylglycerol; GFP, green ﬂuorescent protein;
PKC, protein kinase C; PKD, protein kinase D; PDGF, platelet
derived growth factor; TGN, trans Golgi network
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tion. Locomoting cells exhibit a constant retrograde ﬂow of
membrane proteins from the leading edge of the lamellipodia
backwards, which when coupled to substrate adhesion might
drive forward movement of the cell. In NIH3T3 ﬁbroblasts,
a kinase dead, dominant negative mutant of PKD1 speciﬁcally
inhibited retrograde ﬂow of surface markers as well as ﬁlamen-
tous actin (F-actin) [10]. The observed inhibition of cell motil-
ity was strictly coupled to the block of vesicle transport from
the TGN to the plasma membrane [10], a central function of
PKD [11]. In another study, PKD mediated phosphorylation
of the cell adhesion molecule E-cadherin was associated with
altered cellular aggregation and motility of prostate cancer
cells [12]. Inhibition of PKD1 activity by Go¨6976 resulted in
decreased cellular aggregation, whereas overexpression of
PKD1 increased cellular aggregation and decreased cellular
motility [12]. Taken together, a role of PKD in cell motility be-
comes apparent, supposedly involving quite distinct, direct,
and indirect mechanisms of action. In order to further eluci-
date PKD’s role as a regulator of cell migration we here stud-
ied PKD localization and interacting molecules in murine
pmi28 myoblast cells [13], murine B16-F1 melanoma cells
and human Panc89 pancreas adenocarcinoma cells [14]. Our
data provide evidence that in each of these diﬀerent cell types,
PKD is recruited to sites of actin remodelling at the leading
edge of migrating cells. We further show that PKD directly
interacts with F-actin, phosphorylates cortactin and negatively
regulates cell migration.2. Materials and methods
See Supplementary data.3. Results and discussion
The mouse myoblast cell line pmi28 [13], expresses all three
PKD isoforms as detected by Western blotting and immuno-
ﬂuorescence microscopy, revealing a similar broad cytoplasmic
distribution of the PKD proteins with the expected perinuclear
enrichment and a discrete staining of plasma membrane
stretches (Fig. S1). To investigate the localization of active
PKD we performed a staining with an antibody speciﬁc for
autophosphorylated PKD1 and PKD2 (pS910), showing that
the plasma membrane located PKD is in an active state
(Fig. 1A). Co-staining for F-actin and Arp3 indicated co-local-
ization of active PKD with both of these markers at sites of
membrane protrusions, representing lamellipodia of migratingblished by Elsevier B.V. All rights reserved.
Fig. 1. PKD is recruited to sites of actin remodelling. (A) pmi28 cells stained with antibodies speciﬁc for phosphorylated PKD (pS910) (top and
bottom) and Arp3 (bottom) or with rhodamin-phalloidine (top) to visualize F-actin. Nuclei were stained with Draq5 (blue). (B) pmi28 cells were
treated with PDGF-BB for the indicated time points. PKD was monitored by Western blotting with a phospho-speciﬁc pS910 PKD antibody, and
after stripping with a PKD-speciﬁc antibody. (C) pmi28 cells treated with PDGF-BB and stained for pS910-PKD and F-actin. Arrows indicates co-
localization of PKD and F-actin at the leading edge. Scale bar 10 lm. (D) pmi28 cells were treated as described in (A). 100 cells per coverslip were
quantiﬁed for co-localization of active PKD with F-actin at the leading edge. Results for positive double stained structures were calculated in
percentage of total cells analyzed. The mean values were calculated for three independent experiments and are shown in a graphic with associated
errors (S.D.). Statistically signiﬁcant diﬀerences according to Students paired t-test are marked with an asterisk (*). All images shown are single
confocal sections.
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signals, including growth factors such as Platelet-derived
growth factor (PDGF) [15]. PDGF has clearly been shown
to modulate the formation of lamellipodia [16]. In this line,
we wanted to investigate whether PDGF-stimulation induces
a recruitment of PKD to newly formed lamellipodia. First,
we analyzed the kinetics of PDGF-mediated PKD activation
using autophosphorylation as an indicator. PDGF-BB treat-
ment induced rapid PKD activation peaking at 4–8 min and
returning to basal levels 40 min after onset of PDGF-BB stim-
ulation (Fig. 1B). Next, we monitored the localization of active
PKD in PDGF-induced F-actin positive membrane protru-
sions over time by immunoﬂuorescence microscopy (Fig. 1C)
and quantiﬁed the amount of cells demonstrating co-localiza-
tion of both proteins. The data summarized in Fig. 1C, lower
panel, indicate a rapid recruitment of active PKD into PDGF-
induced membrane protrusion sites. Taken together, these data
suggest an active role of PKD at sites of actin remodelling.
For several protein kinase C (PKC) isoforms, in particular
PKCd, PKCe, PKCbII and PKCf [17–20] direct F-actin bind-ing in vitro has been demonstrated. Although the PKD se-
quence contains no F-actin binding motifs similar to those
present in PKCs [21], the co-localization data (Figs. 1 and 2)
prompted analysis on potential PKD binding to F-actin. To
analyze direct interaction of PKD with F-actin, co-sedimenta-
tion assays using ectopically expressed PKD1-variants or con-
trol lysates from HEK293 cells were performed. As shown in
Fig. 2A, both, PKD1-GFP WT as well as PKD1-KD-GFP
bound to F-actin in vitro. The known F-actin-binding protein
cortactin [22,23] was used as positive control, while green ﬂuo-
rescent protein (GFP) served as respective negative control for
the assays. Of note, also PKD2 demonstrated binding to F-ac-
tin in this assay (Fig. 2A). In order to discriminate between an
indirect PKD recruitment via interaction within multiprotein
complexes at the actin cytoskeleton, or by direct binding to
F-actin, we incubated puriﬁed PKD1 proteins with F-actin.
Both, PKD1 and PKD1-KD, were detected in the pellet frac-
tion (Fig. 2B), indicating that PKD1 directly binds to F-actin
in vitro, independent of its kinase activity. To map the region
responsible for mediating PKD binding to F-actin, several
Fig. 1 (continued)
T. Eiseler et al. / FEBS Letters 581 (2007) 4279–4287 4281
Fig. 2. PKD directly interacts with F-actin in vitro. (A) F-actin co-sedimentation assay with transiently expressed proteins. PKD proteins were
detected by Western blotting with PKD-speciﬁc antibodies. GFP-Vector and FLAG-Cortactin were included as negative and positive controls,
respectively. (B) F-actin co-sedimentation assays with puriﬁed PKD1 and PKD1-KD proteins. Assays without F-actin were included as respective
controls. Actin was detected by Western blotting with an actin-speciﬁc antibody. (C, D) F-actin co-sedimentation assay to map the F-actin binding
domain of PKD1 using total cell lysates from cells expressing PKD1-GFP and respective PKD1-GFP deletion mutants. Assays without F-actin were
included as respective controls. PKD proteins and actin were detected by Western blotting with GFP- and actin-speciﬁc antibodies, respectively. S,
supernatant; P, pellet fraction. (E) Schematic representation of PKD1 WT and deletion mutants. HR, hydrophobic region; AC, acidic domain; PH,
pleckstrin homology domain; CRD, cysteine rich domain; kinase, kinase domain.
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jected to F-actin co-sedimentation assays. A PKD1 mutant
with a deletion of amino acids 1-340 (PKD1D340-GFP) com-
pletely failed to co-sediment with the F-actin fraction, indicat-
ing that the N-terminal regulatory region of PKD is involved
in F-actin binding. Deletion of the PH domain (DPH), the
acidic domain (DAD) or the DAG-binding cystein rich domain
(DCRD) did not aﬀect F-actin binding in vitro (Fig. 2C).Accordingly, the F-actin-binding motif of PKD1 resides
within the N-terminus comprising amino acids 1–146. To test
this, we created a GFP-tagged PKD1 protein lacking the ﬁrst
146 amino acids (PKD1D146-GFP, Fig. 2E) and tested
whether this protein was capable of binding to F-actin.
PKD1D146 failed to co-sediment with the F-actin fraction,
thus conﬁrming our conclusions (Fig. 2D). Based on the fact,
that PKD2 is also capable of binding to F-actin, we suggest
Fig. 3. PKD recruitment is independent of its kinase activity. B16-F1 cells transiently expressing PKD1-GFP, PKD1-KD-GFP and PKD1D340-
GFP proteins were seeded at 30% conﬂuency on laminin-coated coverslips. Cells were treated with aluminoﬂuoride for 20 min, ﬁxed and stained with
rhodamin-phalloidine to visualize F-actin. Shown are single confocal sections. Scale bar 10 lm.
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family members.
To corroborate these ﬁndings, we studied mouse B16-F1
melanoma cells which are used as an in vitro model for alu-
minoﬂuoride (AlF) induced lamellipodia formation [24]. We
studied co-localization of PKD1-GFP wild type (WT), a ki-
nase dead (KD), dominant negative mutant, PKD1-KD-
GFP and PKD1D340-GFP with F-actin, respectively at the
lamellipodium after AIF treatment. Both, PKD1-WT and
PKD1-KD were equally recruited into the leading edge of
B16-F1 cells (Fig. 3). However, PKD1D340 was not found in
areas of actin remodelling at the plasma membrane. These
ﬁndings show that PKD recruitment to the leading edge of
migrating cells was dependent on the aminoterminal domain
and independent of its catalytic activity. This is in accordance
with the present model of stepwise PKD activation, requiring a
DAG dependent membrane recruitment of catalytically inac-tive PKD and a subsequent membrane bound nPKC mediated
transphosphorylation [3,4].
However, it is possible that in addition to a direct F-actin
binding, PKD1 also indirectly associates with F-actin via
known actin binding proteins. In this line, it should be noted,
that PKD1 has been reported to directly associate with cortac-
tin [7] which is enriched in lamellipodia and implicated in the
nucleation and/or stabilization of cortical branched F-actin
networks [22]. In Panc89 cells which showed strong expression
of PKD [25] endogenous PKD displayed cytosolic distribution
with perinuclear enrichment and was also detectable at discrete
plasma membrane protrusions, where it co-localized with F-
actin (Fig. 4A, upper panel) and cortactin (Fig. 4A, lower pa-
nel). An interaction between PKD and cortactin at the leading
edge might involve phosphorylation of cortactin. We therefore
expressed Flag-cortactin together with GFP, PKD1-GFP WT,
and PKD1-KD-GFP and subjected the proteins to an in vitro
Fig. 4. PKD directly phosphorylates cortactin in vitro. (A) Panc89 cells were stained with an antibody speciﬁc for PKD together with rhodamin-
phalloidine to visualize F-actin (upper panel) and an antibody speciﬁc for cortactin (lower panel), respectively. Shown are single confocal sections.
Scale bar 20 lm. (B) Flag-cortactin and the respective GFP-proteins were co-precipitated from cell lysates with anti-Flag and anti-GFP antibodies
and subjected to kinase reaction. Incorporation of radioactive phosphate was analyzed using a PhosphoImager (top), followed by immunoblotting
with Flag-and GFP-speciﬁc antibody to verify equal loading. The bands marked with asterisks are non-speciﬁc.
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presence of PKD1-GFP WT, but not in the presence of PKD1-
KD-GFP or the GFP vector control (Fig. 4B), indicating a
speciﬁc phosphorylation of cortactin by PKD.
In order to assess functional consequences on cell motility of
PKD binding selectively at sites of dynamic actin remodelling,
stable Panc89 cell lines expressing PKD1-GFP wild type and
PKD1-KD-GFP were isolated by G418 selection and multiple
rounds of cell sorting for GFP-expressing cells. Immunoﬂuo-
rescence ﬂow cytometry (data not shown) and Western blot
analyses (Fig. 5A, right panel) of the stable cell lines veriﬁed
transgene expression. PKD1-WT and PKD-KD expressingcells show a similar doubling time and a slightly enhanced pro-
liferation capacity compared to the GFP control (data not
shown). Migration assays were performed using Transwell ﬁl-
ter inserts. Parental (not shown) and GFP vector control cells
showed no diﬀerence in migration behaviour. However, over-
expression of both PKD1 WT and PKD1-KD resulted in
highly signiﬁcant (P < 0.0001) changes, suppressing and
enhancing, respectively, the migration of Panc89 cells through
transwell ﬁlters (Fig. 5A, left panels). In a total of 9 experi-
ments performed on average PKD1 WT reduced the number
of migrating cells to 25.5% and PKD1-KD enhanced the num-
ber of migrating cells to 234.4% of GFP vector control cells. Of
Fig. 5. PKD negatively regulates cell migration. (A, B) Panc89 cells stably expressing GFP, PKD1-GFPWT and PKD1-KD-GFP (A) or cells stably
transfected with pSuppressor-PKD1 plasmid (B, clones 6 and 9) or parental Panc89 cells (A, B, control) were seeded on Transwell ﬁlters and
migration was induced by a FCS gradient of 1–10% FCS. DAPI stained nuclei of migrated cells were used for quantiﬁcation (upper panel). Results
were calculated as median number of migrated cells/visual ﬁeld (lower panels). The assay is representative of at least 3 experiments performed under
the same settings. Expression of transgene was controlled by Western blotting of total cell lysates with a GFP-speciﬁc antibody (A, right panel). Semi-
quantitative RT-PCR of PKD isoforms 1/2/3 and GAPDH from parental Panc89 cells and pSuppressor-PKD1 clones 6 and 9 (B, right panel).
Western blotting of total cell lysates from control and clones 6 and 9 cells with a PKD1 speciﬁc antibody (B, right panel). Detection of tubulin veriﬁes
equal protein loadings (B, right panel).
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notype without a FCS gradient (data not shown).
To further scrutinize the functional role of PKD as a nega-
tive regulator of migration of Panc89 cells, we knocked down
PKD1 expression by RNA interference. Because of the low
eﬃciency of transient RNAi approaches in Panc89 cells we
generated stable knock down clones using a G418 selectable
pSuppressor construct coding for a short interfering RNA
(siRNA) speciﬁc for the PKD1 isoform. During the selection
process, the bulk of primary clones either stopped growing
during the expansion, or detached from the surface, dying sub-
sequently. Only 2 clones survived the selection process and the
expansion to individual, stably growing cell lines. One of these(clone 9) presented as a PKD1-knockdown in semi-quantita-
tive RT-PCR analysis and Western blot analysis (Fig. 5B, right
panels), whereas clone 6 did not display reduced expression of
PKD1, thus serving as a control. PKD2 and PKD3 speciﬁc
RT-PCR veriﬁed a selective knockdown of the PKD1 tran-
scripts in clone 9 PKD1-pSuppressor cells. Transwell migra-
tion assays (Fig. 5B, left panels) revealed strongly increased
migration of the PKD1-knockdown clone (P < 0.0001), when
compared to parental Panc89 cells, or clone 6, which retained
normal PKD1 expression. These results are in accordance with
the phenotype observed upon interference with PKD function
by expression of a dominant negative PKD (Fig. 5A). To-
gether, these data identify PKD as a negative regulator of cell
4286 T. Eiseler et al. / FEBS Letters 581 (2007) 4279–4287migration of Panc89 cells. Because a selective interference with
PKD1 expression already accomplished a phenotype compara-
ble to that observed with functional inhibition of potentially
all PKD isoforms by dominant negative action, an isotype spe-
ciﬁc PKD function in this cell line appears possible.
Depending on the cell model studied, diﬀerent mechanisms
have been proposed through which PKD may inﬂuence cell
motility [7,10,12]. It appears therefore of relevance that in
the murine and human cells of distinct tissue origin studied
here, in each case, active PKD was detectable in places directly
involved in mediating cell motility, pointing to a common
mechanism in these diﬀerent cell types. The co-localization of
PKD with components of the actin branching machinery, such
as Arp3 (this study) and cortactin ([7] and this study) in living
cells, supports a direct role of PKD in dynamic changes of the
branched actin network. Our data also provide a ﬁrst clue as to
the underlying mechanism of PKD mediated regulation of cell
migration through demonstrating direct F-actin binding of
PKD in vitro, and selective co-localization with F-actin at
the leading edge of migrating cells. Interestingly, PKD is not
localized at actin stress ﬁbers, implicating a compartimental-
ized interaction of PKD and F-actin. It is therefore conceiv-
able, that interaction of PKD with the plasma membrane is
a precondition for the direct interaction of both proteins bring-
ing PKD close to F-actin at lamellipodia. Another explanation
would be a recruitment of PKD by other factors to distinctive
sites at the F-Actin network, where it might exert possible
functions in the regulation of actin remodelling. In this context
cortactin would be an ideal candidate to act as a scaﬀolding
protein which could facilitate the recruitment of PKD down-
stream of a PDGF signal since both proteins interact [7].
Moreover, we here demonstrate that cortactin is a potential
novel substrate for PKD at these sites. The role of cortactin
as molecular scaﬀold in actin remodelling is regulated by tyro-
sine and serine/threonine kinases [26]. Phosphorylation of cort-
actin regulates its ability to activate N-WASP as well as F-
actin binding capacity [27,28]. Recently, 17 novel phosphoryla-
tion sites have been identiﬁed in a mass spectrometry ap-
proach, the function of which is still unclear [29]. Based on
our data, we hypothesize that PKD regulates the dynamics
of actin turnover through phosphorylation of proteins of the
actin polymerization machinery, such as cortactin. This may
lead to a stabilization of the cortical actin network, thereby
reducing migration potential.
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